Press Releases

 
Press Releases
  Date Title View
May 4, 2007
BRANFORD, Conn., May 4 /PRNewswire/ -- Marinus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on novel drugs to treat serious neurological disorders, today announced that it is enrolling patients in an international, multi-center, placebo controlled Phase IIb study of its lead compound, Ganaxolone, as an adjunctive treatm...
Feb 28, 2007
BRANFORD, Conn., Feb. 28 /PRNewswire/ -- Marinus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on novel drugs to treat serious neurological disorders, today announced the dosing of the first patient in an international, multi-center, randomized Phase IIb study of its lead compound, ganaxolone, in infants suffering from Infant...
Oct 25, 2005
BRANFORD, Conn., Oct. 25 /PRNewswire/ -- Marinus Pharmaceuticals, Inc., a new developer of drugs to treat serious central nervous system disorders, today announced the closing of a $29.4 million Series A financing round. The financing was led by Domain Associates, Sofinnova Ventures and Canaan Partners, with participation by Foundation Medical P...
FirstPrevious
...
9
= add release to Briefcase